Page last updated: 2024-10-27

2,5-dihydroxybenzoic acid and Benign Neoplasms, Brain

2,5-dihydroxybenzoic acid has been researched along with Benign Neoplasms, Brain in 1 studies

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

Research Excerpts

ExcerptRelevanceReference
" GA enhanced the survival of EAC-bearing mice at a dosage of 0."1.48From epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid. ( Altinoz, MA; Cengiz, S; Elmaci, I; Emekli-Alturfan, E; Ozpinar, A, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altinoz, MA1
Elmaci, I1
Cengiz, S1
Emekli-Alturfan, E1
Ozpinar, A1

Other Studies

1 other study available for 2,5-dihydroxybenzoic acid and Benign Neoplasms, Brain

ArticleYear
From epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid.
    Chemico-biological interactions, 2018, Aug-01, Volume: 291

    Topics: Animals; Aspirin; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cardiotonic Agents; C

2018